News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
643,134 Results
Type
Article (52906)
Company Profile (178)
Press Release (590050)
Section
Business (189043)
Career Advice (2752)
Deals (33994)
Drug Delivery (93)
Drug Development (79650)
Employer Resources (167)
FDA (16422)
Job Trends (15356)
News (327967)
Policy (32959)
Tag
Academia (2851)
Africa (947)
Alliances (46999)
Alzheimer's disease (1198)
Antibody-drug conjugate (ADC) (63)
Approvals (16332)
Arizona (124)
Artificial intelligence (76)
Asia (38673)
Australia (6659)
Bankruptcy (331)
Best Places to Work (11382)
Biosimilars (70)
Biotechnology (125)
C2C Services and Suppliers (71011)
California (1830)
Canada (831)
Cancer (533)
Career advice (2311)
Cell therapy (135)
China (151)
Clinical research (62496)
Collaboration (147)
Colorado (79)
Connecticut (65)
COVID-19 (2728)
Cystic fibrosis (78)
Data (314)
Diabetes (89)
Diagnostics (6157)
Drug pricing (75)
Earnings (72319)
Employer resources (147)
Europe (88224)
Events (88056)
Executive appointments (151)
FDA (16647)
Florida (249)
Funding (143)
Gene therapy (102)
GLP-1 (595)
Government (4653)
Healthcare (18955)
Hotbed/Location (426820)
Illinois (253)
Indiana (145)
Infectious disease (2759)
Inflammatory bowel disease (96)
Interviews (515)
IPO (15095)
Job creations (4084)
Job search strategy (1952)
Kansas (89)
Layoffs (450)
Legal (7505)
Liver cancer (62)
Lung cancer (123)
Manufacturing (95)
Maryland (382)
Massachusetts (1244)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (18761)
Metabolic disorders (285)
Michigan (123)
Minnesota (197)
Neuroscience (1360)
New Jersey (512)
New York (547)
NextGen Class of 2024 (6846)
Non-profit (4871)
North Carolina (605)
Northern California (803)
Obesity (171)
Ohio (96)
Opinion (211)
Patents (67)
Pennsylvania (479)
People (54259)
Phase I (19251)
Phase II (27324)
Phase III (20972)
Pipeline (114)
Postmarket research (2620)
Preclinical (7646)
Press Release (66)
Rare diseases (135)
Real estate (5834)
Recruiting (69)
Regulatory (21799)
Research institute (2524)
Resumes & cover letters (422)
South America (1313)
Southern California (750)
Startups (3590)
Texas (210)
United States (7882)
Vaccines (558)
Washington State (233)
Weight loss (160)
Date
Today (126)
Last 7 days (644)
Last 30 days (2220)
Last 365 days (35844)
2024 (24991)
2023 (38709)
2022 (49565)
2021 (54218)
2020 (53870)
2019 (47649)
2018 (36531)
2017 (33361)
2016 (32315)
2015 (36840)
2014 (28409)
2013 (23508)
2012 (25388)
2011 (26187)
2010 (23544)
643,134 Results for "essilor international sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
Press Releases
Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools
August 1, 2024
·
3 min read
Elastin Biosciences to Participate in 2024 BIO International Convention in San Diego
Elastin Biosciences today announced its participation in this year’s 2024 BIO International Convention, which is being held in San Diego, CA , June 3-6, 2024.
May 30, 2024
·
2 min read
FineHeart Widens International IP Protection for FlowMaker®
FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.
February 20, 2024
·
3 min read
BioMidwest
Humanetics Corporation to Present at the 2024 BIO International Convention in San Diego
Humanetics Corporation is presenting a corporate overview and details on its promising lead radioprotective drug candidate, BIO 300, at the prestigious Biotechnology Innovation Organization International Convention in San Diego, CA next week.
May 31, 2024
·
2 min read
Press Releases
Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)
July 25, 2024
·
1 min read
Pharm Country
Finacity Facilitates MXN 1 Billion Securitization for Laboratorios Sanfer, S.A. de C.V.
Finacity Corporation announced that it has successfully launched a trade receivables securitization for Laboratorios Sanfer, S.A. de C.V.
December 15, 2023
·
2 min read
1 of 64,314
Next
